Other OTC Pharmaceuticals (Pharmacies) - Nepal

  • Nepal
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$6.18m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.90%, resulting in a market volume of US$7.13m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.20 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Nepal has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Nepal have shifted towards over-the-counter (OTC) pharmaceuticals due to several reasons. Firstly, there is a growing awareness among the population about self-medication and the convenience of purchasing OTC drugs without a prescription. This trend is particularly prevalent among the younger generation who are more inclined to seek immediate relief for common ailments. Secondly, the affordability of OTC drugs compared to prescription medications has also contributed to their popularity. With limited healthcare resources and a large portion of the population living in rural areas, OTC drugs provide a cost-effective solution for minor health issues. Trends in the market indicate that the demand for OTC pharmaceuticals in Nepal is on the rise. This can be attributed to several factors. Firstly, the increasing urbanization and population growth in the country have led to a higher demand for healthcare products and services. As more people move to urban areas, the availability and accessibility of pharmacies have improved, making it easier for consumers to purchase OTC drugs. Secondly, the rising prevalence of lifestyle-related diseases such as diabetes, hypertension, and obesity has increased the demand for OTC drugs that cater to these conditions. Consumers are seeking products that can help them manage these chronic diseases without the need for a prescription. Local special circumstances in Nepal have also contributed to the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has a diverse landscape with varying levels of healthcare infrastructure. In rural areas, where access to healthcare facilities is limited, pharmacies play a crucial role in providing basic healthcare services and medications. Additionally, the presence of traditional medicine practices in Nepal has also influenced the demand for OTC pharmaceuticals. Many consumers prefer herbal or alternative remedies for minor ailments, and pharmacies often stock a wide range of these products to cater to this demand. Underlying macroeconomic factors have also played a role in the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Nepal. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and higher purchasing power. As a result, consumers are more willing to spend on healthcare products, including OTC pharmaceuticals. Furthermore, the government has implemented policies to promote the pharmaceutical industry and improve healthcare services, which has created a favorable business environment for pharmacies. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Nepal is developing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The growing awareness and affordability of OTC drugs, increasing urbanization, rising prevalence of lifestyle-related diseases, limited healthcare resources in rural areas, traditional medicine practices, and favorable macroeconomic conditions have all contributed to the growth of this market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)